Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - black snake antivenom, quantity: 18000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a king brown or mulga snake. although the antivenom is effective in the management of patients who are bitten by other members of the genus pseudechis, including the red-bellied or common black snake, tiger snake antivenom is the preferred treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - periciazine, quantity: 2.5 mg - tablet, uncoated - excipient ingredients: wheat starch; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; lactose monohydrate - severe anxiety and tension states and the maintenance treatment of the psychotic patient. it is useful in controlling such symptoms as impulsiveness and aggression.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - lacosamide, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; hyprolose; colloidal anhydrous silica; crospovidone; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black; lecithin; indigo carmine aluminium lake - lacosam tablets are indicated as: ? monotherapy in the treatment of partial seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - lacosamide, quantity: 150 mg - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; hyprolose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black; lecithin - lacosam tablets are indicated as: ? monotherapy in the treatment of partial seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older

Australia - English - Department of Health (Therapeutic Goods Administration)

nova pharmaceuticals australasia pty ltd - black snake antivenom -

Canada - English - Health Canada

total health centre - lac caninum - liquid - 3x - lac caninum 3x - homeopathic products

Canada - English - Health Canada

curanderos ltd. - lac caninum - globules - 3x - lac caninum 3x - homeopathic products

Canada - English - Health Canada

seroyal international inc. - lac caninum - globules - 3x - lac caninum 3x - homeopathic products

Canada - English - Health Canada

homeocan inc. - lac caninum - globules - 3x - lac caninum 3x - homeopathic products

Canada - English - Health Canada

homeocan inc. - lac defloratum - globules - 3x - lac defloratum 3x - homeopathic products